Operator of a biotechnology company intended to develop cellular therapeutic invention to cure cancer. The company's product, Mesenkiller uses a molecule which targets cancer cells that is linked with a radioactive particle killing both targeted and the surrounding non targeted cells, enabling cancer patients with efficient and effective therapeutic without having any systemic affects on the body.